151 related articles for article (PubMed ID: 31570655)
1. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
3. Critical role of notch signaling in osteosarcoma invasion and metastasis.
Zhang P; Yang Y; Zweidler-McKay PA; Hughes DP
Clin Cancer Res; 2008 May; 14(10):2962-9. PubMed ID: 18483362
[TBL] [Abstract][Full Text] [Related]
4. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
5. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
6. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
[TBL] [Abstract][Full Text] [Related]
7. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
8. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
9. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
10. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.
Jin L; Vu T; Yuan G; Datta PK
Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
[TBL] [Abstract][Full Text] [Related]
11. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
12. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
13. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
Yu L; Fan Z; Fang S; Yang J; Gao T; Simões BM; Eyre R; Guo W; Clarke RB
Oncotarget; 2016 May; 7(22):33055-68. PubMed ID: 27102300
[TBL] [Abstract][Full Text] [Related]
15. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
Li Y; Zhang J; Zhang L; Si M; Yin H; Li J
Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952
[TBL] [Abstract][Full Text] [Related]
16. Spindle and kinetochore-related complex subunit 3 has a protumour function in osteosarcoma by activating the Notch pathway.
Liang G; Duan C; He J; Shi L
Toxicol Appl Pharmacol; 2024 Feb; 483():116826. PubMed ID: 38228236
[TBL] [Abstract][Full Text] [Related]
17. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
Zhao YY; Yu GT; Xiao T; Hu J
Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
[TBL] [Abstract][Full Text] [Related]
18. CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway.
Cheng J; Zhang Y; Wan R; Zhou J; Wu X; Fan Q; He J; Tan W; Deng Y
Front Oncol; 2022; 12():919108. PubMed ID: 35957875
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]